DVD. E. Vadiyan

D. E. Vadiyan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


D. E. Vadiyan has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Feactures of mastication and feeding behavior in children with autism spectrum disorder

    by D. E. Vadiyan, O. I. Admakin, L. G. Khachatryan, T. S. Kaminskaya, E. V. Kasanave, T. E. Areian

    INTRODUCTION. Children with autism spectrum disorder (ASD) often exhibit altered oral sensory processing, atypical feeding patterns, and non-standard responses to dental stimuli, complicating endodontic care. AIM. To profile feeding behavior, mastication, and swallowing in ASD and to identify endodontically relevant risks: verification of odontogenic pain, effectiveness of local infiltration anesthesia, and tolerance to rubberdam isolation. MATERIALS AND METHODS. Observational controlled study of 178 children aged 3–9 years (ASD n = 124, controls n = 54). Caregiver questionnaires and clinician-rated protocols assessed meal frequency/duration, oral sensory responses, mastication, and swallowing. Dental visits were evaluated for pain verification, infiltration-anesthesia performance, and isolation tolerance. Between-group differences were tested at α = 0.005, significant effects were observed for all p ≤ 0.003. RESULTS. ASD was associated with more frequent but smaller meals, prolonged mealtimes, heightened oral sensory reactivity, and higher rates of mastication/swallowing difficulties. In the dental setting, ASD patients more often demonstrated hard-to-verify odontogenic pain, variable infiltration-anesthesia efficacy, and poor tolerance to rubber-dam isolation. CONCLUSIONS. The ASD feeding / sensory profile differs from neurotypical peers and predicts challenges in pain verification and treatment tolerance. Routine pre-visit preparation and sensory-aware communication improve cooperation. Stepwise behavior guidance and flexible isolation strategies reduce aversive responses. When infiltration shows inconsistent effect, clinicians should reassess pain source, adapt anesthetic technique, and allow sufficient latency/graded dosing within safety limits. Integrating caregiver-reported feeding / sensory cues into chairside decisions increases anesthesia success and overall endodontic feasibility.

  • Dental status and correction of hygiene status in children with autism spectrum disorders

    by D.E. Vadiyan, F.V. Vadiyan, O.I. Admakin, L.G. Khachatryan, K.A. Kazakova

    To study the dental status and correction of the hygienic status of children with autism spectrum disorder (ASD) 124 children with ASD were examined, the comparison group included 54 normotypical children. Children with ASD (observation group), were divided into 2 groups (by age – from 3 to 5 years 6 months and from 5 years 7 months to 9 years) and four subgroups (by the means of correcting the hygienic status used – Splat foam and Baktoblis oral probiotic). When comparing the age and reason for first to the dentist, a significant difference was found for normotypical children and children with autism: the age of first visit to the dentist for children with autism was 3,9±1,6 years, and for normotypical children 2,9±1,5 years (p<0.0001). In children with autism the number of extracted and carious teeth was 2,5–3 times higner than in normotypical children (p <0.0001). The Fedorov-Volodkina hygienic index in groups of older children with autism was 2,6 times higher than in normotypical children. Against the background of the application of probiotic «Baktoblis» and foam «Splat» platinum a reliable decrease in the amount of plaque Pristley was noted already after 1 month In the older groups, the use of foam “Splat” for 3 months gave a more significant result. In both groups, in the older groups, against the background of the use of foam and probiotic, a reliable decrease in the Fyodorov-Volodkina index was noted.


  • Sleep disorders in children: difficulties in diagnosis and correction

    by L.G. Khachatryan, N.A. Geppe, N.YU. Golovanova, T.S. Kaminskaya, Moscow V.F.VOyno-Yasenetsky Scientific And Practical Center Of Specialized Medical Care For Children, E.N. Tyurina, E.V. Kasanave, D.E. Vadiyan, A.V. Polyanskaya, S.N. Chebysheva, et al.

    The article is devoted to one of the topical problems in paediatrics and child neurology - sleep disorders in children. This problem requires special attention due to its high incidence, clinical polymorphism and complexity of correction. Objective. To evaluate the efficacy of Homeostres preparation for the correction of sleep disorders in children. Patients and methods. A total of 112 patients aged 3 to 5 years 11 months (63% boys and 37% girls) were under observation. All children included in the study were distributed into 2 groups of 56 patients each using the method of simple randomisation. Group 1 patients received Homeostres 2 tablets 3 times a day without meals for 28 days. Patients of group 2 received gamma aminobutyric acid preparation in age-appropriate dose. All patients were observed 2 times: before the start of treatment (Visit 1) and on the 28th day (Visit 2) of the conducted therapy. The effectiveness of therapy was assessed taking into account the characteristics of emotional-behavioural sphere, characteristics of sleep/sleep quality using a special questionnaire, as well as the IMPSS parental assessment scale. Laboratory and instrumental studies included clinical blood analysis to exclude inflammatory process, transcranial dopplerography of cerebral vessels and 3-hour electroencephalographic monitoring of the brain. Results. All examined children initially had different degrees of sleep and sleep disorders within the framework of the diagnosis ‘insomnia’. The positive effect of Homeostres administration on all stages of sleep: initiation and consolidation, especially on the duration and nature of falling asleep, sleep phase and number of night awakenings was verified by statistical analysis. According to the data presented, the number of night awakenings decreased significantly during Homeostres administration: the number of children with 6 and more night awakenings decreased, the number of children with 5 night awakenings decreased by 1.5 times, the number of children falling asleep independently increased by 2 times (p < 0.008) and the number of children rocking to sleep decreased by 1.3 times. Parents reported decreased wakefulness and nighttime wakefulness and 67% of parents of children receiving Homeostres were satisfied with the outcome of the intervention. After 28 days of Homeostres, the duration of nocturnal sleep increased by an average of one hour and ranged from 7 to 12 hours M = 9 9 9 (SD = 1, CV = 13.2%, р = 0.001)), the average duration of nocturnal wakefulness decreased by a factor of 1.1 to 1.5 1.7 1.9 ± 0.5 hours (CV = 37.6%, р = 0.0001), and the duration of the sleep period decreased by a factor of 1.2 to an average of 32 34 36 min (SD = 6, CV = 18.1%). There was also a significant improvement of blood flow in the main great cerebral vessels and improvement of venous outflow in the vein of Galen, which can be partially explained by the presence of sympatho-regulating and vagolytic herbal components in Homeostres. Good tolerability of Homeostres in children and absence of adverse reactions were also noted. Comparative analysis with patients taking gamma aminobutyric acid showed no significant difference in the efficacy of the two drugs. Conclusion. The efficacy of the drug Homeostres for the correction of sleep disorders in children over 3 years of age has been demonstrated on representative material. The use of the drug improves sleep parameters, it has a good efficacy and safety profile, and can be recommended for widespread use in paediatric healthcare.

  • Open Access

    Preventing Oral Health Problems in Children with Autism Spectrum Disorder: A Feasible Mission?

    by D. E. Vadiyan, O. I. Admakin, L. G. Khachatryan, T. S. Kaminskaya, N. S. Morozova, E. N. Tyurina, T. E. Areyan

    Relevance. Children with autism spectrum disorder (ASD) frequently exhibit poorer oral hygiene and altered oral and gut microbiota, influenced by behavioral features, sensory hypersensitivity, and feeding difficulties. Evidence for non-invasive, home-based caries-prevention strategies in this population remains limited. The evaluation of the clinical efficacy of available preventive agents, including calcium-enriched oral foam and the oral probiotic Streptococcus salivarius K12, is considered a relevant topic of investigation in pediatric dentistry. Materials and methods. In this prospective controlled study, 122 children with ASD aged 3–9 years received 30-day preventive regimens including a calcium-enriched oral foam (Group 1) or S. salivarius K12 (Group 2). A control group comprised 54 neurotypical children. Oral health status was assessed using the Fedorov–Volodkina Hygiene Index; the presence and severity of black stain plaque (extrinsic discoloration) were recorded clinically; caries experience was quantified as the combined dmft + DMFT score. Oral and fecal microbiota were profiled by GC–MS. Results. At baseline, children with ASD had significantly poorer oral hygiene and higher caries prevalence than neurotypical controls. GC–MS profiling indicated pronounced dysbiosis in both oral and intestinal samples in the ASD cohort, with correlations across sites for pathogenic taxa ( e.g., Streptococcus mutans, Staphylococcus aureus, Helicobacter pylori ). A statistically significant decrease in oral hygiene index scores was observed in both younger and older age groups following the use of calcium-enriched oral foam and the Streptococcus salivarius K12 probiotic. After 30 days of preventive use, the proportion of children with elevated levels of S. mutans , S. aureus , and other pathogenic microorganisms decreased in oral and gut samples. No statistically significant between-regimen differences in improvement were observed across age groups. Both interventions demonstrated comparable efficacy. Conclusion. Calcium-enriched oral foam and S. salivarius K12, used as home-based adjuncts, improved plaque-related indices and favorably modulated microbiota profiles in children with ASD. These non-invasive measures may be recommended as part of comprehensive dental care for this population.